Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Octreotide for cirrhosis after variceal bleeding. Authors' claims for octreotide were not justified.

× No keyword cloud information.

6 in total

1. Tables of the number of patients required in clinical trials using the logrank test.

Authors: L S Freedman
Journal: Stat Med Date: 1982 Apr-Jun Impact factor: 2.373

2. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study.

Authors: J Vorobioff; R J Groszmann; E Picabea; M Gamen; R Villavicencio; J Bordato; I Morel; M Audano; H Tanno; E Lerner; M Passamonti
Journal: Gastroenterology Date: 1996-09 Impact factor: 22.682

3. Randomised trial of octreotide for long term management of cirrhosis after variceal haemorrhage.

Authors: S A Jenkins; J N Baxter; M Critchley; A N Kingsnorth; C A Makin; S Ellenbogen; J S Grime; J G Love; R Sutton
Journal: BMJ Date: 1997-11-22

Review 4. Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly.

Authors: J C Gillis; S Noble; K L Goa
Journal: Drugs Date: 1997-04 Impact factor: 9.546

5. The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage.

Authors: P A McCormick; M Y Morgan; A Phillips; T P Yin; N McIntyre; A K Burroughs
Journal: J Hepatol Date: 1992-01 Impact factor: 25.083

6. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic Club.

Authors: M Primignani; B Andreoni; L Carpinelli; A Capria; G Rocchi; I Lorenzini; C Staudacher; L Beretta; R Motta; R de Franchis
Journal: Hepatology Date: 1995-05 Impact factor: 17.425

6 in total